151 related articles for article (PubMed ID: 37498992)
1. Synergistic anti-tumour activity of ginsenoside Rg3 and doxorubicin on proliferation, metastasis and angiogenesis in osteosarcoma by modulating mTOR/HIF-1α/VEGF and EMT signalling pathways.
Zeng X; Liu S; Yang H; Jia M; Liu W; Zhu W
J Pharm Pharmacol; 2023 Nov; 75(11):1405-1417. PubMed ID: 37498992
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells.
Kim JW; Jung SY; Kwon YH; Lee JH; Lee YM; Lee BY; Kwon SM
Cancer Biol Ther; 2012 May; 13(7):504-15. PubMed ID: 22406998
[TBL] [Abstract][Full Text] [Related]
3. Ginsenosides Inhibit the Proliferation of Lung Cancer Cells and Suppress the Rate of Metastasis by Modulating EGFR/VEGF Signaling Pathways.
Yu X; Wang Q; Dai Z
J Oleo Sci; 2024; 73(2):219-230. PubMed ID: 38311411
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway.
Cao Y; Ye Q; Zhuang M; Xie S; Zhong R; Cui J; Zhou J; Zhu Y; Zhang T; Cao L
PLoS One; 2017; 12(11):e0186520. PubMed ID: 29140979
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg3 inhibits HIF-1α and VEGF expression in patient with acute leukemia via inhibiting the activation of PI3K/Akt and ERK1/2 pathways.
Zeng D; Wang J; Kong P; Chang C; Li J; Li J
Int J Clin Exp Pathol; 2014; 7(5):2172-8. PubMed ID: 24966925
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rg3 Suppresses Proliferation and Induces Apoptosis in Human Osteosarcoma.
Li Y; Lu J; Bai F; Xiao Y; Guo Y; Dong Z
Biomed Res Int; 2018; 2018():4306579. PubMed ID: 29750154
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer.
Xu TM; Xin Y; Cui MH; Jiang X; Gu LP
Chin Med J (Engl); 2007 Apr; 120(7):584-8. PubMed ID: 17442207
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg3 induces DNA damage in human osteosarcoma cells and reduces MNNG-induced DNA damage and apoptosis in normal human cells.
Zhang YH; Li HD; Li B; Jiang SD; Jiang LS
Oncol Rep; 2014 Feb; 31(2):919-25. PubMed ID: 24337872
[TBL] [Abstract][Full Text] [Related]
9. An mTOR and VEGFR inhibitor combination arrests a doxorubicin resistant lung metastatic osteosarcoma in a PDOX mouse model.
Oshiro H; Tome Y; Miyake K; Higuchi T; Sugisawa N; Kanaya F; Nishida K; Hoffman RM
Sci Rep; 2021 Apr; 11(1):8583. PubMed ID: 33883561
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary study for the roles and mechanisms of 20(R)-ginsenoside Rg3 and PEG-PLGA-Rg3 nanoparticles in the Lewis lung cancer mice].
Geng L; Fan J; Gao QL; Yu J; Hua BJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Jun; 48(3):496-501. PubMed ID: 27318914
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice.
Liu TG; Huang Y; Cui DD; Huang XB; Mao SH; Ji LL; Song HB; Yi C
BMC Cancer; 2009 Jul; 9():250. PubMed ID: 19624862
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rg3 alleviates the migration, invasion, and angiogenesis of lung cancer cells by inhibiting the expressions of cyclooxygenase-2 and vascular endothelial growth factor.
Lv Q; Xia Z; Huang Y; Ruan Z; Wang J; Huang Z
Chem Biol Drug Des; 2023 Apr; 101(4):937-951. PubMed ID: 36593682
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rg3 inhibits endothelial progenitor cell differentiation through attenuation of VEGF-dependent Akt/eNOS signaling.
Kim JW; Jung SY; Kwon YH; Lee SH; Lee JH; Lee BY; Kwon SM
Phytother Res; 2012 Sep; 26(9):1286-93. PubMed ID: 22253055
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitory Effect of Ginsenoside Rg3 Combined With 5-Fluorouracil on Tumor Angiogenesis and Tumor Growth of Colon Cancer in Mice: An Experimental Study].
Zhao Y; Deng L; Cao Y; Ma B; Li Y; Xu J; Li H; Huang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 55(1):111-117. PubMed ID: 38322531
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg3 inhibits osteosarcoma progression by reducing circ_0003074 expression in a miR-516b-5p/KPNA4-dependent manner.
Wang T; Zhang C; Wang S
J Orthop Surg Res; 2021 Dec; 16(1):724. PubMed ID: 34930332
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rg3 enhances radiosensitization of hypoxic oesophageal cancer cell lines through vascular endothelial growth factor and hypoxia inducible factor 1α.
Ge X; Zhen F; Yang B; Yang X; Cai J; Zhang C; Zhang S; Cao Y; Ma J; Cheng H; Sun X
J Int Med Res; 2014 Jun; 42(3):628-40. PubMed ID: 24691458
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the hypoxia-induced factor-1α and vascular endothelial growth factor expression through ginsenoside Rg3 in human gastric cancer cells.
Li B; Qu G
J Cancer Res Ther; 2019; 15(7):1642-1646. PubMed ID: 31939450
[TBL] [Abstract][Full Text] [Related]
18. Role of crosstalk between STAT3 and mTOR signaling in driving sensitivity to chemotherapy in osteosarcoma cell lines.
Wang YT; Tang F; Hu X; Zheng CX; Gong TJ; Zhou Y; Luo Y; Min L
IUBMB Life; 2020 Oct; 72(10):2146-2153. PubMed ID: 33448097
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rg3 regulates DNA damage in non-small cell lung cancer cells by activating VRK1/P53BP1 pathway.
Liu T; Zuo L; Guo D; Chai X; Xu J; Cui Z; Wang Z; Hou C
Biomed Pharmacother; 2019 Dec; 120():109483. PubMed ID: 31629252
[TBL] [Abstract][Full Text] [Related]
20. Combining combretastatin A4 phosphate with ginsenoside Rd synergistically inhibited hepatocellular carcinoma by reducing HIF-1α via PI3K/AKT/mTOR signalling pathway.
Yang X; Gao M; Miao M; Jiang C; Zhang D; Yin Z; Ni Y; Chen J; Zhang J
J Pharm Pharmacol; 2021 Mar; 73(2):263-271. PubMed ID: 33793802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
